<DOC>
	<DOCNO>NCT01661842</DOCNO>
	<brief_summary>Autoimmune hepatitis ( AIH ) characterize chronic inflammation liver , interface hepatitis , hypergammaglobulinemia , presence autoantibody . Disease presentation vary typically base characteristic aminotransferase elevation , histological abnormality , elevate level serum globulin , presence one autoantibody . Two type juvenile AIH identify accord seropositivity smooth muscle /or antinuclear antibody ( AIH type 1 ) liver kidney microsomal antibody ( AIH type 2 ) . Standard therapy clinic consist combination corticosteroid azathioprine , display efficacy 80 % patient . However , 7 % patient deteriorate despite compliance standard corticosteroid regiment ( treatment failure ) ,13 % patient improve degree satisfies remission criterion ( incomplete response ) , 13 % patient develop serious drug-induced complication , 50 % -86 % patient relapse drug withdrawal . These serious drawback counterbalance benefit conventional therapy , compel reason refine current treatment strategy pursue alternative therapy . UC-MSC application treatment several severe autoimmune disease , immune thrombocytopenia , systemic lupus erythematosus , therapy-resistant rheumatoid arthritis . In study , safety efficacy UC-MSC transplantation AIH patient evaluate .</brief_summary>
	<brief_title>Umbilical Cord Mesenchymal Stem Cells Patients With Autoimmune Hepatitis</brief_title>
	<detailed_description>Autoimmune hepatitis ( AIH ) immune-mediated necroinflammatory disease liver characterize elevation IgG , presence characteristic autoantibody , histological feature interface hepatitis . Standard therapy consist combination corticosteroid azathioprine , efficacious 80 % patient . However , current treatment strategy complicate frequent relapse drug withdrawal , medication intolerance , refractory disease . Alternative medical therapy may need AIH . The potential stem cell differentiate hepatocytes cell recently confirm . In particular , bone marrow-derived mesenchymal stem cell ( BM-MSC ) transplantation applicated clinic treat several human disease GVHD , cardiac injury brain injury , display good tolerance efficiency . Recently , umbilical cord-derived MSCs ( UC-MSC ) also use treat severe autoimmune disease , immune thrombocytopenia , systemic lupus erythematosus , therapy-resistant rheumatoid arthritis . The purpose study learn whether UC-MSC improve disease condition patient autoimmune hepatitis ( AIH ) . This study also look well UC-MSC tolerate safety AIH patient Participants study randomly assign one two treatment arm : Arm A : Participants receive 12 week UC-MSC treatment plus conventional treatment ( combination corticosteroid azathioprine ) Arm B : Participants receive 12 week placebo plus conventional treatment . ( combination corticosteroid azathioprine ) UC-MSC prepared accord standard procedure collect plastic bag contain anticoagulant . UC-MSCs give via i.v . sonography monitoring . After cell therapy , patient follow week 12 , 24 , 36 , 48 , 72 , 96 . The evaluation clinical parameter level serum alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , Î³-globulin , total bilirubin ( TB ) , prothrombin time ( PT ) , albumin ( ALB ) , prealbumin ( PA ) IgG , detect time point . MELD score , Liver histology , treatment side effect , relapse rate clinical symptom also observe simultaneously .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Autoimmune</mesh_term>
	<criteria>1 . Written inform consent 2 . Autoimmune hepatitis ( accord criterion define international autoimmune hepatitis Group , Hepatology , 2008 ; 48:169176 ) 3 . Negative pregnancy test ( female patient fertile age ) 1 . Hepatocellular carcinoma Malignancies 2 . Pregnant lactate woman 3 . Viral Hepatitis ( HAV , HBV , HCV , et al ) 4 . Vital organ failure ( Cardiac , Renal Respiratory , et al ) 5 . Sepsis 6 . Active thrombosis portal hepatic vein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Autoimmune Hepatitis</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>serum albumin</keyword>
	<keyword>serum Tbil</keyword>
	<keyword>serum immunoglobulin G ( IgG )</keyword>
</DOC>